Partnering & Collaborations

Established Collaborations

Pantherna Therapeutics is seeking for diverse types of collaborations with pharmaceutical and biotech companies.

  • The Company plans to partner its in-house development programs at the pre-clinical or clinical stage.
  • One of Pantherna’s programs focuses on patients with an Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition associated with viral and bacterial lung infections.
  • In addition, Pantherna is interested in research collaborations and pre-clinical development agreements with industry partners to extend the applications of Pantherna’s proprietary lipid nanoparticle mRNA expression technology platforms (PTX_LNP®, PTXmRNA®).
  • Pantherna is open to research agreements with academia and biotech that have complementary research interest and corresponding capabilities in selected indications proposed by the respective partner.


Business Development Contact

  • Individuals or organizations interested in exploring potential collaboration opportunities are invited to contact:
    Dr. Klaus Giese, CEO

    k.giese@pantherna-therapeutics.com